Primary care engagement in hidradenitis suppurativa: Influence of disease severity, cardiometabolic risk, and access barriers.

Authors

Charlotte McRae, Sivani B Reddy, Michael Anderson, Laci Turner, Tiffany Mayo

Published in

Dermatology online journal. Volume 32. Issue 2. May 08, 2026. Epub May 08, 2026.

Abstract

Hidradenitis suppurativa (HS) is linked to cardiometabolic disease (CMD), and guidelines recommend annual primary care visits. This study examined predictors of primary care utilization among patients with HS.
In this cross-sectional study, 307 patients with HS were analyzed. χ² tests, one-way analysis of variance, and multivariable logistic regression assessed associations among barriers to care, primary care provider (PCP) adherence, HS severity, and CMD presence.
Mean age was 39.4 years; 26.4% had Hurley stage III disease. Overall PCP adherence was 85.0% but lower in patients under 30 years (71.0%). CMD prevalence included hypertension (33.9%), type 2 diabetes (17.6%), and hypercholesterolemia (32.9%). Patients without CMD were 74.0% less likely to adhere to annual PCP visits (adjusted odds ratio [AOR], 0.26; P = .001), and being uninsured reduced adherence by 82.0% (AOR, 0.18; P = .01). HS severity did not predict adherence, but Hurley stage III disease was associated with more PCP visits and independently predicted type 2 diabetes (AOR, 2.26; P = .02).
Primary care engagement is influenced more by CMD and insurance than HS severity. Coordinated dermatology-primary care strategies may enhance preventive care, especially for younger patients without CMD.

PMID:
42522477
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.